FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Denies Ferring Reconsideration Petition

FDA denies a Ferring Pharmaceuticals petition asking the agency to reconsider its earlier denial of a petition seeking restrictions on ANDAs citing Fi...

latest-news-card-1
Human Drugs

Test and Report Leachable Nitrosamines: FDA

An FDA guidance asks manufacturers and applicants of drug products packed in infusion bags to collect and report data on nitrosamine impurities that c...

Medical Devices

NeuroOnes Trigeminal Nerve Ablation Cleared

FDA clears a NeuroOne Medical Technologies 510(k) to market its OneRF Trigeminal Nerve Ablation System for use in procedures to create radiofrequency ...

latest-news-card-1
Human Drugs

Cancer Radiopharm. Dosage Guide

FDA posts a new draft guidance entitled Oncology Therapeutic Radiopharmaceuticals (RPTs): Dosage Optimization During Clinical Development.

latest-news-card-1
Human Drugs

Stealth Refiles NDA for Barth Syndrome Drug

Stealth BioTherapeutics resubmits its NDA for elamipretide for treating Barth syndrome.

latest-news-card-1
Human Drugs

Court Orders FDA to Reconsider Vanda sNDA

An appeals court rules that FDA improperly rejected Vanda Pharmaceuticals request for a hearing on its supplemental NDA for sleep drug Hetlioz (tasime...

FDA General

Advisory Panel Conflicts of Interest Low: Study

A new study in JAMA finds that conflicts of interest among federal vaccine advisors had fallen to historic lows well before HHS secretary Robert F. Ke...

Medical Devices

Tandem Recalls Insulin Pumps Due to Alarm Error

Tandem Diabetes Care recalls (Class 1 device correction) certain t:slim X2 insulin pumps to address a potential speaker-related issue that can trigger...

latest-news-card-1
Human Drugs

Workshop on Patient Experience Data in Drug Development

FDA announces a two-day virtual public workshop to address methodological challenges in using patient experience data in drug development and regulato...

latest-news-card-1
Human Drugs

Wegovoy OKd for Metabolic Steatohepatitis

FDA grants Novo Nordisk accelerated approval for a new Wegovy (semaglutide) indication for treating metabolic dysfunction-associated steatohepatitis.